Skip to main content
CLSDQ logo

CLSDQ · Clearside Biomedical, Inc. · Short Interest

Track CLSDQ — free
Market Cap
$1.30M
Shares
5.23M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

CLSDQ Latest Reported Short Interest

FINRA reported 95,698 CLSDQ shares sold short as of the June 30, 2026 settlement date, unchanged from the previous report. Days to cover was 18.07 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

No active listed options were found.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-18 18:35 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-30 Scheduled
FINRA publishes Oct 9
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-06-30 95,698 95,698 0 18.07
2026-06-15 95,698 95,794 -96 8.50
2026-05-29 95,794 107,196 -11,402 7.66
2026-05-15 107,196 110,633 -3,437 23.09
2026-04-30 110,633 83,291 +27,342 1.59
2026-04-15 83,291 83,291 0 1.45
2026-03-31 83,291 81,392 +1,899 1.32
2026-03-13 81,392 75,468 +5,924 4.60
2026-02-27 75,468 68,923 +6,545 2.58
2026-02-13 68,923 52,901 +16,022 1.61
2026-01-30 52,901 9,693 +43,208 1.00
2026-01-15 9,693 23,990 -14,297 1.00
2025-12-31 23,990 67,452 -43,462 1.00
2025-12-15 67,452 757,199 -689,747 1.00

Full FINRA short interest reporting calendar

Showing 1–14 of 14 settlements
Key facts CIK 1539029 CUSIP 185063203 Visit website Investor relations